PTCE Practice Test

Answer choices

1. A. Anyone can report to VAERS; it is an early-warning system, not proof of causation
2. B. Only manufacturers can report, and submission establishes confirmed causation
3. C. The event must be handled solely as an ordinary drug recall rather than a vaccine-safety report
4. D. VAERS accepts reports only after a court determines the vaccine caused the event

Wrong-answer review

• B. Only manufacturers can report, and submission establishes confirmed causation: Reporting is not limited to manufacturers, and acceptance does not confirm causation.
• C. The event must be handled solely as an ordinary drug recall rather than a vaccine-safety report: A possible vaccine event belongs in the vaccine-safety reporting pathway rather than solely an ordinary recall workflow.
• D. VAERS accepts reports only after a court determines the vaccine caused the event: No court finding is required before a suspected event may be reported to VAERS.

Answer choices

1. A. Dispense because confirmed identity makes temperature history and dating irrelevant; involve the pharmacist before completing that step
2. B. Use the longest in-use date found on any insulin product
3. C. Treat current room temperature as proof that no earlier excursion occurred
4. D. Quarantine it for pharmacist review of the uncertain temperature exposure and verify the exact product's labeled in-use dating

Answer choices

1. A. Classify albuterol as the maintenance corticosteroid and approve unlimited early refills; involve the pharmacist before completing that step
2. B. Recognize albuterol as a rescue beta2 agonist for bronchospasm; refer the frequent-use and maintenance-therapy report to the pharmacist
3. C. Tell the patient to use albuterol only for bacterial respiratory infections
4. D. Remove the inhaled corticosteroid from the profile because rescue therapy always replaces maintenance treatment

Answer choices

1. A. Use the ordinary return because manufacturer credit removes controlled status
2. B. Place it in routine trash after the credit is posted
3. C. Use authorized controlled-substance return or destruction and retain required records
4. D. Erase it from inventory before arranging disposition so the counts remain balanced

Answer choices

1. A. Process it because a complete prescription shifts all responsibility to the prescriber; involve the pharmacist before completing that step
2. B. Hold it; give the altered and inconsistent information to the pharmacist
3. C. Replace the phone number in the record and accept the overwritten quantity without review
4. D. Ask the patient which quantity was intended and use that answer to complete the fill

Answer choices

1. A. Dispense it because a successful barcode scan verifies every required element
2. B. Replace the expiration label and use the package because the drug name matched
3. C. Investigate dosage-form and expiration mismatches; do not rely on the scan
4. D. Override the visual checks because manually questioning a scan increases workflow variation

Answer choices

1. A. 12 days
2. B. 24 days
3. C. 63 days
4. D. 62 days

Answer choices

1. A. A normal label automatically creates REMS authorization for every product
2. B. Requirements from any unrelated REMS program can be reused without verification
3. C. Complete medication-specific REMS authorization and safe-use documentation
4. D. Skip certification because REMS requirements apply only to manufacturers

Answer choices

1. A. Stop pickup; give the medication, diet, supplement, and bleeding information to the pharmacist
2. B. Dispense it because diet and supplements cannot affect INR response; involve the pharmacist before completing that step
3. C. Tell the patient to double the next warfarin dose to replace blood lost from the nosebleeds
4. D. Remove the bleeding report because minor symptoms do not belong in a medication profile

Answer choices

1. A. Separate products, use Tall Man lettering, and verify the full label
2. B. Rely only on the first three letters of each drug name
3. C. Ignore the route and indication because matching the shelf location is sufficient
4. D. Remove strength and dosage form from the comparison so the names are easier to read